About Komodo Health
Komodo Health was founded in 2014 by Arif Nathoo, Web Sun, and Ryan Schneider, building what the company describes as a "Healthcare Map," a large-scale database aggregating de-identified patient encounter and claims data across a very significant share of the U.S. patient population, aiming to give a comprehensive, longitudinal view of how patients move through the healthcare system, including their diagnoses, treatments, and outcomes over time across different providers and care settings, a more complete picture than any single health system, insurer, or provider network typically has visibility into given how fragmented most individual patients' care and data actually is across multiple different providers and systems over their lifetime.
Komodo's platform uses this aggregated healthcare data to support a range of use cases across the healthcare industry, including helping pharmaceutical companies understand the epidemiology and treatment patterns for specific diseases to inform drug development and commercial strategy, helping identify patients who might benefit from clinical trial participation or existing approved therapies they may not currently be receiving, and helping healthcare providers and payers identify care gaps and opportunities to improve patient outcomes and reduce unnecessary healthcare spending. The company has emphasized its data's scale and completeness as a key differentiator, arguing that its Healthcare Map's breadth across care settings and geography gives customers meaningfully more complete visibility into real-world patient care patterns than more narrowly scoped healthcare datasets that might only capture claims data or only data from a specific set of health systems or insurance plans. Komodo's customers span pharmaceutical and biotech companies, healthcare providers, and health insurance payers, all of which increasingly rely on large-scale, real-world healthcare data to inform decision-making across drug development, clinical operations, and population health management. The company has raised very substantial venture funding from investors including Andreessen Horowitz, Baillie Gifford, and Tiger Global, reaching a valuation exceeding $3.5 billion, competing with other healthcare data analytics companies including IQVIA and Truveta.
